Latest News

Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque Psoriasis
Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque Psoriasis

March 22nd 2024

Papp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.

Exploring the Link Between COVID-19 Research and Psoriatic Disease
Exploring the Link Between COVID-19 Research and Psoriatic Disease

March 19th 2024

FDA Approves Boehringer Ingelheim's Spesolimab-sbzo For Adults and Children With Generalized Pustular Psoriasis
FDA Approves Boehringer Ingelheim's Spesolimab-sbzo For Adults and Children With Generalized Pustular Psoriasis

March 19th 2024

Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis Management
Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis Management

March 15th 2024

Frontline Forum Part 2: Challenges and Opportunities to Enhance Psoriasis Management
Frontline Forum Part 2: Challenges and Opportunities to Enhance Psoriasis Management

March 14th 2024

Video Interviews
Podcasts
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
The Cutaneous Connection
The Cutaneous Connection: Episode 29- Do Diet and Supplements Affect Psoriasis?
The Cutaneous Connection

More News

© 2024 MJH Life Sciences

All rights reserved.